Repositioning of the β-Blocker Carvedilol as a Novel NLRP3 Inflammasome Inhibitor
博士 === 國防醫學院 === 生命科學研究所 === 107 === The NLRP3 inflammasome is a multiprotein complex that plays a key role in the innate immune system, and aberrant activation of this complex is involved in the pathogenesis of inflammatory diseases. Carvedilol (CVL) is an α-, β-blocker used to treat high blood pre...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2019
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/7t6u4t |